Gene · 5947
Papers1,641
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,641
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single Nucleotide Polymorphisms Associated with Rheumatoid Arthritis in Saudi Patients. | J Clin Med | 2023 | 37568346 | PubTator, text mining | PubMed |
| Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | 37564980 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. | Cell Commun Signal | 2023 | 37537585 | PubTator, text mining | PubMed |
| Small molecule targeting of transcription-replication conflict for selective chemotherapy. | Cell Chem Biol | 2023 | 37531956 | PubTator, text mining | PubMed |
| Role of Bubble Evolution in the Bubble-Propelled Janus Micromotors. | Micromachines (Basel) | 2023 | 37512766 | PubTator, text mining | PubMed |
| Construction, Expression, and Evaluation of the Naturally Acquired Humoral Immune Response against Plasmodium vivax RMC-1, a Multistage Chimeric Protein. | Int J Mol Sci | 2023 | 37511330 | PubTator, text mining | PubMed |
| Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors. | Med Sci (Basel) | 2023 | 37489462 | PubTator, text mining | PubMed |
| Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers. | Explor Target Antitumor Ther | 2023 | 37455825 | PubTator, text mining | PubMed |
| MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation. | Nucleic Acids Res | 2023 | 37395406 | PubTator, text mining | PubMed |
| Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues. | Cancer Med | 2023 | 37392167 | PubTator, text mining | PubMed |
| Classification and deep-learning-based prediction of Alzheimer disease subtypes by using genomic data. | Transl Psychiatry | 2023 | 37386009 | PubTator, text mining | PubMed |
| The Effect of 5-aza,2'-deoxyCytidine (5 AZA CdR or Decitabine) on Extrinsic, Intrinsic, and JAK/STAT Pathways in Neuroblastoma and Glioblastoma Cells Lines. | Asian Pac J Cancer Prev | 2023 | 37378911 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Reelin through the years: From brain development to inflammation. | Cell Rep | 2023 | 37339050 | PubTator, text mining | PubMed |
| New roles for elongation factors in RNA polymerase II ubiquitylation and degradation. | Biochim Biophys Acta Gene Regul Mech | 2023 | 37331651 | PubTator, text mining | PubMed |
| S-Palmitoylation during Retinoic Acid-Induced Neuronal Differentiation of SH-SY5Y Neuroblastoma Cells. | J Proteome Res | 2023 | 37294931 | PubTator, text mining | PubMed |
| Vitamin A: too good to be bad? | Front Pharmacol | 2023 | 37284305 | PubTator, text mining | PubMed |
| The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. | Front Pharmacol | 2023 | 37251321 | PubTator, text mining | PubMed |
| Nutritional Factors: Benefits in Glaucoma and Ophthalmologic Pathologies. | Life (Basel) | 2023 | 37240765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5947/papers?page=6